نتائج البحث - "Pappacena, Jeremy"

1

دورية أكاديمية

Busulfan/Melphalan/Fludarabine (Bu/Mel/Flu) Conditioning Versus Total Body Irradiation/Thiotepa/Cyclophosphamide (HFTBI/Thio/Cy) Based Conditioning in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Undergoing CD34-Selected T-Cell Depleted Allogeneic Stem Cell Transplantation (alloSCT)

المؤلفون: Orozco, Jennifer S., Hilden, Patrick, Maloy, Molly A., Pappacena, Jeremy, Buie, Larry W., Shaffer, Brian C., Papadopoulos, Esperanza B., Jakubowski, Ann A., Bhatt, Valkal

المصدر: Biology of Blood and Marrow Transplantation ; volume 25, issue 3, page S276-S277 ; ISSN 1083-8791

مصطلحات موضوعية: Transplantation, Hematology

الإتاحة: https://doi.org/10.1016/j.bbmt.2018.12.342Test
https://api.elsevier.com/content/article/PII:S1083879118311649?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1083879118311649?httpAccept=text/plainTest

View record in BASE

2

دورية أكاديمية

More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

المؤلفون: Pappacena, Jeremy, Bhatt, Valkal, Shah, Gunjan L., Hilden, Patrick, Maloy, Molly, Buie, Larry W., Giralt, Sergio A., Scordo, Michael

المصدر: Biology of Blood and Marrow Transplantation ; volume 24, issue 3, page S330-S331 ; ISSN 1083-8791

مصطلحات موضوعية: Transplantation, Hematology

الإتاحة: https://doi.org/10.1016/j.bbmt.2017.12.271Test
https://api.elsevier.com/content/article/PII:S1083879117311680?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1083879117311680?httpAccept=text/plainTest

View record in BASE

3

دورية أكاديمية

Drug interactions with Bruton’s tyrosine kinase inhibitors: clinical implications and management

المؤلفون: Fancher, Karen M., Pappacena, Jeremy J.

المصدر: Cancer Chemotherapy and Pharmacology ; volume 86, issue 4, page 507-515 ; ISSN 0344-5704 1432-0843

مصطلحات موضوعية: Pharmacology (medical), Cancer Research, Pharmacology, Toxicology, Oncology

الإتاحة: https://doi.org/10.1007/s00280-020-04137-6Test

View record in BASE

4

دورية أكاديمية

No Loose Ends: A Review of the Pharmacotherapy of Hairy Cell and Hairy Cell Leukemia Variant

المؤلفون: King, Amber C., Kabel, Charlene C., Pappacena, Jeremy J., Stump, Sarah E., Daley, Ryan J.

المصدر: Annals of Pharmacotherapy ; volume 53, issue 9, page 922-932 ; ISSN 1060-0280 1542-6270

مصطلحات موضوعية: Pharmacology (medical)

الإتاحة: https://doi.org/10.1177/1060028019836775Test

View record in BASE

5

دورية أكاديمية

Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia

المؤلفون: King, Amber C., Pappacena, Jeremy J., Tallman, Martin S., Park, Jae H., Geyer, Mark B.

المساهمون: Lymphoma Research Foundation, American Society of Hematology

المصدر: Leukemia Research ; volume 79, page 27-33 ; ISSN 0145-2126

مصطلحات موضوعية: Cancer Research, Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.leukres.2019.02.009Test
https://api.elsevier.com/content/article/PII:S0145212619300359?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0145212619300359?httpAccept=text/plainTest

View record in BASE

6

دورية أكاديمية

Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia.

المؤلفون: Daley, Ryan J., Rajeeve, Sridevi, Kabel, Charlene C., Pappacena, Jeremy J., Stump, Sarah E., Lavery, Jessica A., Tallman, Martin S., Geyer, Mark B., Park, Jae H.

المصدر: Leukemia & Lymphoma; Jan2021, Vol. 62 Issue 1, p176-184, 9p

مصطلحات موضوعية: LYMPHOBLASTIC leukemia, ACUTE leukemia, ADULTS, ASPARAGINASE, ASPARAGINE

7

دورية

Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation

المؤلفون: Xiao, Wenbin, Yabe, Mariko, Offin, Michael, Khattar, Pallavi, Baik, Jeeyeon, Daley, Ryan J., Pappacena, Jeremy J., Roshal, Mikhail, Zhang, Yanming, Tallman, Martin S., Cai, Sheng F.

المصدر: Blood Advances; July 2018, Vol. 2 Issue: 13 p1517-1521, 5p

النص الكامل

8

دورية

Pegaspargase Can Safely be Administered in Adults Age 40 and Older with Acute Lymphoblastic Leukemia

المؤلفون: Daley, Ryan J., Rajeeve, Sridevi, Kabel, Charlene C., Pappacena, Jeremy J., Stump, Sarah E., Lavery, Jessica A., Tallman, Martin S., Geyer, Mark B., Park, Jae H.

المصدر: Blood; November 2019, Vol. 134 Issue: Supplement 1 p3816-3816, 1p

النص الكامل

9

دورية أكاديمية

395 - More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT)

المؤلفون: Pappacena, Jeremy¹, Bhatt, Valkal¹, Shah, Gunjan L.², Hilden, Patrick³, Maloy, Molly², Buie, Larry W.¹, Giralt, Sergio A.², Scordo, Michael²

المصدر: Biology of Blood & Marrow Transplantation. Mar2018 Supplement, Vol. 24, pS330-S331. 1p.

النص الكامل

10

دورية

Blinatumomab Administered Concurrently with Oral Tyrosine Kinase Inhibitor Therapy Is a Well-Tolerated Consolidation Strategy and Eradicates Measurable Residual Disease in Adults with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

المؤلفون: King, Amber C., Pappacena, Jeremy, Tallman, Martin S., Park, Jae H., Geyer, Mark Blaine

المصدر: Blood; November 2018, Vol. 132 Issue: Supplement 1 p1414-1414, 1p

النص الكامل

تنقيح النتائج